Blog
RSS FeedPosted by Michael Wonder on 07 Dec 2023
‘Learning each other’s language’: FDA, patent office seek to work together to lower drug prices
7 December 2023 - In 1997, Celgene obtained a key patent for what would become a blockbuster blood cancer treatment, ...
Posted by Michael Wonder on 02 Dec 2023
China’s new cancer drug toripalimab is approved in the US but will cost 30 times more
29 November 2023 - In China, a single dose vial costs US$280 but in the US it will have a wholesale ...
Posted by Michael Wonder on 08 Nov 2023
Biogen-Sage Therapeutics post partum depression pill priced at $15,900
7 November 2023 - Sage Therapeutics has priced the oral post partum depression pill it developed with partner Biogen at ...
Posted by Michael Wonder on 23 Oct 2023
Ozempic and Wegovy don’t cost what you think they do
22 October 2023 - Drug companies are making billions from a new class of in demand weight loss treatments. But the ...
Posted by Michael Wonder on 21 Oct 2023
Rezolute receives Priority Medicines (PRIME) eligibility from EMA for enhanced regulatory support of RZ358 in congenital hyperinsulinism
17 October 2023 - PRIME eligibility granted based on key positive data from the Phase 2B (RIZE) study and current ...
Posted by Michael Wonder on 15 Jun 2023
Coherus resolves part of dispute with AbbVie over Humira biosimilar
16 June 2023 - Coherus BioSciences said on Thursday it had agreed to retract a restraining order against AbbVie as ...
Posted by Michael Wonder on 07 Jun 2023
‘We don’t agree’ on drug pricing policy, FDA chief tells biotech leaders
7 June 2023 - The drug industry has spent the past year speaking against new mechanisms that could limit how ...
Posted by Michael Wonder on 02 Jun 2023
Coherus announces industry wide lowest list price for adalimumab biosimilar Yusimry (adalimumab-aqvh) launching in July 2023
1 June 2023 - List price of $995 per carton for two 40 mg/0.8 mL auto-injectors. ...
Posted by Michael Wonder on 11 Feb 2023
State of the Union highlights America’s awkward conversation on financing the development of new medicines
9 February 2023 - Science, medicine, health care, and paying for medicines featured prominently in President Joe Biden’s State of ...
Posted by Michael Wonder on 30 Jan 2023
US law makers call on Biden Administration to lower the price of enzalutamide
27 January 2023 - US Senator Elizabeth Warren, a Democrat from Massachusetts, and nearly two dozen other lawmakers are demanding to ...
Posted by Michael Wonder on 26 Jan 2023
Patent reform and lower drug prices should be bipartisan priorities
25 January 2023 - As the 118th Congress convenes this month in Washington D.C., many pundits and advocates have little ...
Posted by Michael Wonder on 25 Jan 2023
Pricing of medicines in Switzerland | Three yearly price review: What are the most important changes for 2023?
24 January 2023 - The Federal Office of Public Health reviews the price of every medicinal product that is reimbursed under ...
Posted by Michael Wonder on 21 Jan 2023
Stop blaming Biogen for putting profit at the expense of patients. Blame the systems that enabled it.
17 January 2023 - Two congressional committees recently released damning results of an 18 month investigation into the FDA’s approval of ...
Posted by Michael Wonder on 19 Jan 2023
The battle over European drug pricing
19 January 2023 - UK and EU must balance health cost control with plans to grow life sciences. ...
Posted by Michael Wonder on 10 Jan 2023
Moderna considers price of $110-$130 for COVID-19 vaccine
9 January 2023 - Commercial price is similar to Pfizer’s plans for after government contracting ends. ...